Latest Breaking News On - Presentation form - Page 1 : comparemela.com

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates (ADCs) from its oncology pipeline are presented at the American Association for Cancer Research (AACR) Annual Meetin

Innovent biologicsBispecific antibodiesPresentation formPoster sectionInnovent biologicsAbstract numberSolid tumorsSafety profile